Shares of Marksans Pharma Ltd. will be in focus on Wednesday, June 11, after a significant block deal took place during Tuesday’s trading session. As per exchange data, 1,02,73,443 shares of the company changed hands at an average price of ₹249.95 per share, translating to a total deal value of approximately ₹257 crore.
While the identities of the buyers and sellers involved in the transaction remain undisclosed, CNBC-TV18 had earlier reported that global healthcare investment firm OrbiMed Asia IV Mauritius FVCI Ltd was looking to offload up to 2.27% stake in Marksans Pharma via block deals. The expected deal size was pegged at ₹256.8 crore.
As per the latest shareholding pattern, OrbiMed held a 10.88% stake in Marksans Pharma as of the March 2025 quarter.
Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information.
